J.F. Timp

1.5k total citations · 1 hit paper
15 papers, 1.0k citations indexed

About

J.F. Timp is a scholar working on Internal Medicine, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, J.F. Timp has authored 15 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Internal Medicine, 7 papers in Cardiology and Cardiovascular Medicine and 6 papers in Surgery. Recurrent topics in J.F. Timp's work include Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Diagnosis and Treatment of Venous Diseases (6 papers). J.F. Timp is often cited by papers focused on Venous Thromboembolism Diagnosis and Management (15 papers), Atrial Fibrillation Management and Outcomes (7 papers) and Diagnosis and Treatment of Venous Diseases (6 papers). J.F. Timp collaborates with scholars based in Netherlands, Norway and Singapore. J.F. Timp's co-authors include Suzanne C. Cannegieter, Sigrid K. Brækkan, Henri H. Versteeg, Willem M. Lijfering, Frits R. Rosendaal, Saskia le Cessie, Astrid van Hylckama Vlieg, Linda E. Flinterman, John‐Bjarne Hansen and Peter Kubisz and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS Medicine.

In The Last Decade

J.F. Timp

13 papers receiving 1.0k citations

Hit Papers

Epidemiology of cancer-associated venous thrombosis 2013 2026 2017 2021 2013 250 500 750

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.F. Timp Netherlands 8 803 509 244 196 189 15 1.0k
Oliver Königsbrügge Austria 20 643 0.8× 549 1.1× 174 0.7× 137 0.7× 163 0.9× 52 1.2k
Frits I. Mulder Netherlands 12 805 1.0× 523 1.0× 138 0.6× 272 1.4× 154 0.8× 31 1.0k
Victor E D Yosuico Canada 20 757 0.9× 445 0.9× 170 0.7× 395 2.0× 204 1.1× 26 1.0k
Anand Lokare United Kingdom 9 934 1.2× 752 1.5× 201 0.8× 318 1.6× 223 1.2× 20 1.1k
Frederick A. Meyers United States 11 603 0.8× 342 0.7× 257 1.1× 188 1.0× 137 0.7× 11 905
Simon Mantha United States 17 532 0.7× 473 0.9× 414 1.7× 116 0.6× 107 0.6× 57 1.1k
Anthonie W.A. Lensing Netherlands 11 805 1.0× 476 0.9× 287 1.2× 178 0.9× 270 1.4× 14 1.0k
Rekha Parameswaran United States 15 422 0.5× 353 0.7× 426 1.7× 141 0.7× 136 0.7× 33 1000
Martha Louzada Canada 13 511 0.6× 368 0.7× 308 1.3× 225 1.1× 157 0.8× 78 801
Juliana Perez Botero United States 12 470 0.6× 391 0.8× 310 1.3× 156 0.8× 152 0.8× 37 852

Countries citing papers authored by J.F. Timp

Since Specialization
Citations

This map shows the geographic impact of J.F. Timp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.F. Timp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.F. Timp more than expected).

Fields of papers citing papers by J.F. Timp

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.F. Timp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.F. Timp. The network helps show where J.F. Timp may publish in the future.

Co-authorship network of co-authors of J.F. Timp

This figure shows the co-authorship network connecting the top 25 collaborators of J.F. Timp. A scholar is included among the top collaborators of J.F. Timp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.F. Timp. J.F. Timp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Timp, J.F., Luuk J.J. Scheres, Linda E. Flinterman, et al.. (2024). Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women. Journal of Thrombosis and Haemostasis. 22(8). 2195–2202. 2 indexed citations
2.
Yap, Eng Soo, Willem M. Lijfering, J.F. Timp, et al.. (2023). Procoagulant factors and future risk of arterial cardiovascular disease in patients with prior venous thrombosis: A cohort study. SHILAP Revista de lepidopterología. 4(1). 3–12. 2 indexed citations
3.
Timp, J.F., Sigrid K. Brækkan, Willem M. Lijfering, et al.. (2021). Correction: Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP). PLoS Medicine. 18(4). e1003612–e1003612. 4 indexed citations
4.
Lijfering, Willem M., J.F. Timp, & Suzanne C. Cannegieter. (2019). Predicting the risk of recurrent venous thrombosis: What the future might bring. Journal of Thrombosis and Haemostasis. 17(9). 1522–1526. 7 indexed citations
5.
Timp, J.F., Sigrid K. Brækkan, Willem M. Lijfering, et al.. (2019). Prediction of recurrent venous thrombosis in all patients with a first venous thrombotic event: The Leiden Thrombosis Recurrence Risk Prediction model (L-TRRiP). PLoS Medicine. 16(10). e1002883–e1002883. 39 indexed citations
6.
Timp, J.F., Willem M. Lijfering, Frits R. Rosendaal, Saskia le Cessie, & Suzanne C. Cannegieter. (2019). Risk prediction of recurrent venous thrombosis; where are we now and what can we add?. Journal of Thrombosis and Haemostasis. 17(9). 1527–1534. 8 indexed citations
7.
Nemeth, Banne, J.F. Timp, Astrid van Hylckama Vlieg, Frits R. Rosendaal, & Suzanne C. Cannegieter. (2018). High risk of recurrent venous thrombosis in patients with lower‐leg cast immobilization. Journal of Thrombosis and Haemostasis. 16(11). 2218–2222. 10 indexed citations
8.
Sokol, Juraj, J.F. Timp, Saskia le Cessie, et al.. (2018). Mild antithrombin deficiency and risk of recurrent venous thromboembolism: results from the MEGA follow‐up study. Journal of Thrombosis and Haemostasis. 16(4). 680–688. 28 indexed citations
9.
Timp, J.F., Suzanne C. Cannegieter, Sigrid K. Brækkan, et al.. (2017). Antibiotic use as a marker of acute infection and risk of first and recurrent venous thrombosis. British Journal of Haematology. 176(6). 961–970. 11 indexed citations
10.
Yap, Eng Soo, J.F. Timp, Linda E. Flinterman, et al.. (2015). Elevated levels of factor VIII and subsequent risk of all‐cause mortality: results from the MEGA follow‐up study. Journal of Thrombosis and Haemostasis. 13(10). 1833–1842. 18 indexed citations
11.
Timp, J.F., Willem M. Lijfering, Linda E. Flinterman, et al.. (2015). Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow‐up study. Journal of Thrombosis and Haemostasis. 13(10). 1823–1832. 60 indexed citations
12.
Timp, J.F., Bernardine H. Stegeman, Linda E. Flinterman, et al.. (2013). Recurrent venous thrombosis in premenopausal women : effect of hormonal contraceptive use. Journal of Thrombosis and Haemostasis. 11. 115–116.
13.
Timp, J.F., et al.. (2013). Predictive value of high factor VIII levels for recurrent venous thrombosis. Journal of Thrombosis and Haemostasis. 11. 50–51. 1 indexed citations
14.
Timp, J.F., et al.. (2013). The risk of venous thrombosis in patients with malignancy is largely mediated through levels of factor VIII and von Willebrand factor. Journal of Thrombosis and Haemostasis. 11. 93–94.
15.
Timp, J.F., Sigrid K. Brækkan, Henri H. Versteeg, & Suzanne C. Cannegieter. (2013). Epidemiology of cancer-associated venous thrombosis. Blood. 122(10). 1712–1723. 822 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026